Delivery Order SPE2DB20D2104-SPE2DB25FMRMW
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,470.05 on August 28, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement executed under the company's larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,176.82 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is scheduled for ultimate completion on July 29, 2025, with performance to be completed at the vendor's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $2,435.62 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Clomid 50 mg tablets in unit dose packages of 30 units. The contract is a firm fixed price delivery order with an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order valued at $3,513.70 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30s) on September 12, 2025, with an ultimate completion date of September 15, 2025. The contract utilizes firm fixed price pricing and was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30 count) with a ceiling value of $3,506.24. This competitive delivery order, which employs firm fixed price contracting, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order carries no set-aside designation and is...
- The Defense Logistics Agency awarded a $10,034.90 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging of 30-count quantities. The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of September 3, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,135.42 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count) on August 26, 2025, with completion targeted for August 27, 2025. The contract employs firm fixed price terms and includes no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this procurement action....
- The Defense Logistics Agency awarded a delivery order valued at $1,432.77 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30 count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,492.20 for Clomid 50 mg tablets (30-count unit dose packaging) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, non-set-aside contract operates under firm fixed pricing and represents a child order issued against AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's headquarters location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging of 30 tablets. This competitively awarded, non-set-aside contract carries a ceiling value of $9,458.24 under firm fixed price terms, with an ultimate completion date of July 24, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMRMWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,214.10 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 7, 2025. The contract is performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of federal contracts with DLA covering diverse therapeutic domains including specialty medications, brand-name and generic drugs, and vaccines to support the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/6/25 |